Abstract
A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such 'frequent flyers' who were provided with continuous subcutaneous insulin infusion (CSII) therapy. Mean HbA1c decreased from 9.7 +/- 2.5% (83 +/- 27 mmol/mol) to 7.9 +/- 0.4% (63 +/- 4.7 mmol/mol) after 2-4 months. Frequency of admissions for acute glycaemic events reduced in three but increased in two patients within 6 months. Total insulin dose and body mass index decreased in some patients and satisfaction was anecdotally higher. Some, but not all, 'frequent flyers' benefited from a trial of CSII.
| Original language | English |
|---|---|
| Pages (from-to) | 1706-1711 |
| Number of pages | 6 |
| Journal | Internal Medicine Journal |
| Volume | 53 |
| Issue number | 9 |
| Publication status | Published - Sept 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.
Open Access - Access Right Statement
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.Keywords
- type 1
- mental health
- patient readmission
- diabetes mellitus
- glycaemic control
- insulin infusion systems
